case 3: molecular testing in bladder cancer
Published 4 years ago • 98 plays • Length 7:12Download video MP4
Download video MP3
Similar videos
-
4:18
case 3: treatment for fgfr3 bladder cancer
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
2:13
case 3: mutational patterns in bladder cancer
-
1:32
case 3: relapsed muscle-invasive bladder cancer, fgfr3
-
8:29
case 4: considering special populations in bladder cancer
-
1:26
analyzing the role of molecular profiling in patients with bladder cancer
-
0:46
molecular markers guiding treatment approaches in bladder cancer
-
43:48
urinary molecular marker tests in bladder cancer: an overview of cxbladder
-
7:07
applying recent developments in targeted molecular therapeutics for advanced bladder cancer
-
1:29
dr. bochner on the standardization of molecular profiling in bladder cancer
-
1:25
additional insights: fgfri-associated ocular aes in bladder cancer
-
13:53
molecular testing and treatment sequencing for advanced uc: navigating fgfr-targeted therapy
-
1:48
dr. bochner on molecular profiling in bladder cancer
-
1:45:10
masterclass in bladder cancer
-
2:14
how does targeted therapy treat bladder cancer?
-
6:58
case 2: factors in treating cis-ineligible bladder cancer
-
1:24
next steps in neoadjuvant chemotherapy for muscle-invasive bladder cancer
-
7:14
genetic testing for bladder cancer - urology care foundation
-
8:35
case 1: novel agents in superficial bladder cancer